Further the downregulation of IRS-1, SIRT1 and GLUT-4 and upregulation of ADAM 17 demonstrates its potential impact on glucose homeostasis, insulin resistance and chronic inflammatory markers. The gene discussed is SLC2A4; the disease is Insulin resistance.